about
Developments in Intralesional Therapy for Metastatic MelanomaThe Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.Climacostol reduces tumour progression in a mouse model of melanoma via the p53-dependent intrinsic apoptotic programme.Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy.Intralesional immunotherapy as a strategy to treat melanoma.A practical guide to the handling and administration of talimogene laherparepvec in Europe.Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release.Talimogene laherparepvec: overview, combination therapy and current practices
P2860
Q28069615-4F359BFC-5A79-4CA3-9D6E-F293F3A7E2C6Q36102807-366BAD28-0A27-4E2B-8466-A7381987445BQ36974284-A348ED3A-5B2F-4C76-A463-746EE55B601BQ38630561-67AF5E92-0C3F-485A-919B-0FAF698235F8Q38742761-DAE15F2D-CE4E-4504-8027-0792FDDACA14Q40080717-353C2642-01AC-4F26-99C8-6312AF712798Q42976672-F27432DE-4E95-4C14-975E-AB048A43D701Q56894524-7869A9B0-B951-49CF-A75C-552AF1930509
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Intralesional therapy for metastatic melanoma.
@en
type
label
Intralesional therapy for metastatic melanoma.
@en
prefLabel
Intralesional therapy for metastatic melanoma.
@en
P2860
P1476
Intralesional therapy for metastatic melanoma.
@en
P2093
Jonathan S Zager
Sarah Sloot
P2860
P304
P356
10.1517/14656566.2014.967682
P407
P577
2014-11-07T00:00:00Z